Related Experiment Video
Updated: Aug 28, 2025

Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Paraneoplastic pemphigus associated with Castleman disease: A multicenter case series
Kelly K Barry1, Isabella Plumptre2, Christopher G Bazewicz3
1Department of Dermatology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Paraneoplastic pemphigus (PNP) in children is often linked to Castleman disease (CD). Complete resection of unicentric CD improves survival, even with complications like bronchiolitis obliterans.
Area of Science:
- Autoimmune diseases
- Pediatric oncology
- Rare diseases
Background:
- Paraneoplastic pemphigus (PNP) is a rare, severe autoimmune blistering disease.
- In pediatric cases, PNP frequently co-occurs with Castleman disease (CD).
Purpose of the Study:
- To describe clinical characteristics and outcomes of pediatric patients with PNP associated with CD.
- To identify prognostic factors for survival in this patient cohort.
Main Methods:
- Retrospective review of medical records for patients aged ≤22 years diagnosed with PNP and CD.
- Inclusion criteria: clinical and immunopathologic evidence of PNP; histopathologic diagnosis of CD.
Main Results:
- Five patients (2 children, 2 adolescents, 1 young adult) were included, with a mean age of 11.8 years.
- Common manifestations included oral and anogenital mucositis; four patients had unicentric CD (UCD) and one had multicentric CD (MCD).
- Survival was associated with UCD and complete CD resection; mortality was linked to MCD, incomplete resection, and bronchiolitis obliterans (BO).
Conclusions:
- Unicentric CD, particularly with complete resection, is associated with better outcomes in pediatric PNP.
- PNP should be considered in pediatric mucositis cases, as it can mimic other conditions.
- Prognosis is significantly impacted by the type of CD, surgical completeness, and presence of BO.
More Related Videos
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
09:08Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021